Pierfranco Conte - Dissemin

Language
Login

All papers authored by Pierfranco Conte

This paper was not found in any repository, but could be made available legally by the author.

2021 Maria Vittoria Dieci

ORCID

, Valentina Guarneri, Anna Tosi, Giancarlo Bisagni, Antonino Musolino

ORCID

, Simon Spazzapan, Gabriella Moretti, Grazia Maria Vernaci

ORCID

, Gaia Griguolo

ORCID

, Tommaso Giarratano

ORCID

, Loredana Urso, Francesca Schiavi

ORCID

, Claudia Pinato, Giovanna Magni, Marcello Lo Mele and 3 other authors

Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Valentina Guarneri

ORCID

, Carlo Alberto Giorgi

ORCID

, Saverio Cinieri

ORCID

, Carmelo Bengala, Gabriella Mariani, Giancarlo Bisagni, Antonio Frassoldati, Claudio Zamagni, Costanza De Rossi, Vito Amoroso

ORCID

, Claudia Andreetta, Antonella Ferro, Alberto Zambelli, Stefania Gori, Ornella Garrone

ORCID

and 11 other authors

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Patrick Neven, Stephen R. D. Johnston, Masakazu Toi

ORCID

ORCID

, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda

ORCID

, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, PierFranco Conte

ORCID

, Yi Lu

ORCID

, Nadine Haddad and 3 other authors

MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2−-Advanced Breast Cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Eva Maria Ciruelos, Hope S. Rugo

ORCID

, Ingrid A. Mayer

ORCID

, Christelle Levy, Frédéric Forget, Juan Ignacio Delgado Mingorance, Juan Ignacio Delgado Mingorance, Tamar Safra

ORCID

, Norikazu Masuda

ORCID

, Yeon Hee Park, Dejan Juric

ORCID

, Pierfranco Conte

ORCID

, Mario Campone, Sibylle Loibl

ORCID

ORCID

and 5 other authors

Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1

Upload

This paper is made freely available by the publisher.

Hesham Elghazaly

ORCID

, Hope S. Rugo, Hamdy A. Azim, Sandra M. Swain, Banu Arun, Matti Aapro, Edith A. Perez, Benjamin O. Anderson, Frederique Penault-Llorca, Pierfranco Conte

ORCID

, Nagi S. El Saghir

ORCID

, Cheng-Har Yip, Marwan Ghosn, Philip Poortmans

ORCID

, Mohamed A. Shehata and 24 other authors

Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer

Download from doi.org

This paper is made freely available by the publisher.

Francesco Schettini

ORCID

, Mario Giuliano, Fabiola Giudici

ORCID

, Benedetta Conte

ORCID

, Pietro De Placido, Sergio Venturini, Carla Rognoni

ORCID

, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro

ORCID

, Fabio Puglisi

ORCID

, PierFranco Conte

ORCID

, Michelino De Laurentiis

ORCID

, Lajos Pusztai

ORCID

and 6 other authors

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Tomás Pascual

ORCID

, Aranzazu Fernandez-Martinez, Maki Tanioka, M. Vittoria Dieci

ORCID

ORCID

, Joaquin Gavila, Valentina Guarnieri, Javier Cortes

ORCID

, Patricia Villagrasa, Núria Chic, Maria Vidal

ORCID

, Barbara Adamo, Montserrat Muñoz, Gaia Griguolo

ORCID

, Antonio Llombart

ORCID

and 8 other authors

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor–Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti–HER2-Based Therapy

Upload

This paper is made freely available by the publisher.

Denis Horgan, Gennaro Ciliberto

ORCID

, Pierfranco Conte

ORCID

, Giuseppe Curigliano, Luis Seijo, Luis M. Montuenga

ORCID

, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle Ray-Coquard

ORCID

, Denis Querleu, Peter Riegman, Keith Kerr, Hein Van Poppel, Anders Bjartell and 15 other authors

Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 Valentina Guarneri, Maria Vittoria Dieci

ORCID

, Giancarlo Bisagni, Alba A. Brandes, Antonio Frassoldati, Luigi Cavanna

ORCID

, Antonino Musolino

ORCID

, Francesco Giotta

ORCID

, Anita Rimanti, Ornella Garrone

ORCID

, Elena Bertone, Katia Cagossi, Oriana Nanni, Federico Piacentini

ORCID

, Enrico Orvieto and 8 other authors

PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype.

Upload

This paper is made freely available by the publisher.

Gaia Griguolo

ORCID

, Fara Brasó-Maristany

ORCID

, Blanca González-Farré, Tomás Pascual

ORCID

, Núria Chic, Tamara Saurí, Ronald Kates, Oleg Gluz, Débora Martínez, Laia Paré, Vassilena Tsvetkova, David Pesantez, Maria Vidal

ORCID

, Barbara Adamo, Montserrat Muñoz and 14 other authors

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

Download from doi.org

This paper is made freely available by the publisher.

Stefano Frega, Alessandro Dal Maso

ORCID

, Giulia Pasello, Lea Cuppari

ORCID

, Laura Bonanno

ORCID

, PierFranco Conte

ORCID

, Laura Evangelista

ORCID

Novel Nuclear Medicine Imaging Applications in Immuno-Oncology

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Francesco Schettini

ORCID

, Fabiola Giudici

ORCID

, Mario Giuliano

ORCID

, Massimo Cristofanilli, Grazia Arpino

ORCID

, Lucia Del Mastro, Fabio Puglisi

ORCID

, Sabino De Placido, Ida Paris, Pietro De Placido, Sergio Venturini, Michelino De Laurentis, PierFranco Conte

ORCID

, Dejan Juric, Antonio Llombart-Cussac and 5 other authors

Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis

Upload

This paper was not found in any repository, but could be made available legally by the author.

Antonio Frassoldati, Laura Biganzoli

ORCID

, Roberto Bordonaro, Saverio Cinieri, Pierfranco Conte

ORCID

, Michelino De Laurentis, Lucia Del Mastro, Stefania Gori, Rossella Lauria, Paolo Marchetti, Andrea Michelotti, Filippo Montemurro, Giuseppe Naso, Paolo Pronzato, Fabio Puglisi

ORCID

and 1 other authors

Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

Upload

This paper was not found in any repository, but could be made available legally by the author.

Alessandro Dal Maso

ORCID

, Martina Lorenzi, Elisa Roca, Sara Pilotto, Marianna Macerelli, Valentina Polo, Fabiana Letizia Cecere, Alessandro Del Conte, Giorgia Nardo, Vanessa Buoro, Daniela Scattolin, Sara Monteverdi, Loredana Urso, Elisabetta Zulato, Stefano Frega and 5 other authors

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy

Upload

Distributing this paper is prohibited by the publisher

George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, PierFranco Conte

ORCID

, Yi Lu, Susana Barriga

ORCID

and 4 other authors

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

Upload

This paper is made freely available by the publisher.

2019 Maria Vittoria Dieci, Giancarlo Bisagni, Alba A. Brandes, Antonio Frassoldati, Luigi Cavanna, Francesco Giotta, Michele Aieta, Vittorio Gebbia, Antonino Musolino

ORCID

, Ornella Garrone, Michela Donadio, Anita Rimanti, Alessandra Beano, Claudio Zamagni, Hector Soto Parra and 17 other authors

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Mark Robson

ORCID

, Kathryn J. Ruddy

ORCID

ORCID

, Elżbieta Senkus

ORCID

, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Wei Li, Nadine Tung, Anne Armstrong, Suzette Delaloge, Wendy Bannister, Carsten Goessl, Arnold Degboe, Robert Hettle and 1 other authors

Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial

Upload

This paper is made freely available by the publisher.

A. Pavan, I. Attili, G. Pasello, V. Guarneri, P. F. Conte

ORCID

ORCID

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

Download from doi.org

This paper is made freely available by the publisher.

Zoltan Lohinai, Laura Bonanno, Aleksei Aksarin, Alberto Pavan, Zsolt Megyesfalvi, Balazs Santa, Virag Hollosi, Balazs Hegedus, Judit Moldvay, PierFranco Conte

ORCID

, Mikhail Ter-Ovanesov, Evgeniy Bilan, Balazs Dome, Glen J. Weiss

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Edith A. Perez

ORCID

, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young‐Hyuck Im, Pierfranco Conte

ORCID

, Miguel Martin, Tadeusz Pienkowski, Xavier B. Pivot, Howard A. Burris, Jennifer A. Petersen, Sanne De Haas, Silke Hoersch, Monika Patre, Paul Anthony Ellis

Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2–positive advanced breast cancer: Final results from MARIANNE

Upload

Missing publications? Search for publications with a matching author name.